The Wet Seal (NASDAQ:WTSL) EVP Lesli Gilbert acquired 10,000 shares of the company’s stock on the open market in a transaction that occurred on Wednesday, April 2nd. The shares were purchased at an average cost of $1.36 per share, with a total value of $13,600.00. Following the acquisition, the executive vice president now directly owns 99,929 shares in the company, valued at approximately $135,903.The Wet Seal, Inc. (NASDAQ:WTSL) shares after opening at $1.14 on last trade day and at the end of the day closed at $1.13. Company price to sales ratio in past twelve months was calculated as 0.18 and price to cash ratio as 2.07. The Wet Seal, Inc. (NASDAQ:WTSL) showed a negative weekly performance of -4.24%.
One of Equal Energy Ltd. (USA) (NYSE:EQU)’s largest shareholders wants the company to buy back nearly half of its outstanding stock instead of proceeding with a proposed sale. Montclair Energy LLC on Friday proposed a levered share repurchase to boost the value of Equal’s stock.Alabama-based Montclair previously had balked at the sale proposal Equal announced in December. It also failed in its bid to acquire the company earlier last year. Equal Energy Ltd. (USA) (NYSE:EQU) shares moved up 7.09% in last trading session and was closed at $4.68, while trading in range of $4.32 – $4.80. Equal Energy Ltd. (USA) (NYSE:EQU) year to date (YTD) performance is -12.36%.
Old Second Bancorp (NASDAQ:OSBC) saw strong trading volume on Wednesday following insider buying activity, AnalystRatingsNetwork reports. 212,961 shares traded hands during mid-day trading, an increase of 23% from the previous session’s volume of 172,577 shares.The stock last traded at $4.90 and had previously closed at $4.81. Old Second Bancorp Inc. (NASDAQ:OSBC) shares fell -2.45% in last trading session and ended the day on $4.77. OSBC return on equity ratio is recorded as 209.80% and its return on assets is 3.90%. Old Second Bancorp Inc. (NASDAQ:OSBC) yearly performance is 44.55%.
OHR Pharmaceutical Inc (NASDAQ:OHRP)’s announced that it has entered into subscription agreements with institutional and accredited investors for the sale of its common stock in a registered direct offering. The Company is selling 1.8 million shares of common stock at a price of $10.00 per share, for gross proceeds of approximately $18 million. Chardan Capital Markets, LLC acted as lead placement agent and Brean Capital, LLC acted as co-placement agent for the offering. Ohr intends to use the proceeds of the offering for general corporate purposes, including expenses for clinical trials, research and development, general and administrative, manufacturing, and potential acquisitions of complementary companies and/or technologies that complement the company’s business. OHR Pharmaceutical Inc (NASDAQ:OHRP) weekly performance is -28.55%. On last trading day company shares ended up $9.96. OHR Pharmaceutical Inc (NASDAQ:OHRP) distance from 50-day simple moving average (SMA50) is -32.43%. Analysts mean target price for the company is $21.00.